jeudi 17 janvier 2019

F.D.A. Panel Splits on Whether to Approve New Diabetes Drug

The advisory committee voted 8-8 on approving the drug, to be called Zynquista, which would be the first oral medication for people with Type 1 diabetes.

from NYT > Health https://nyti.ms/2ARVIUR
via health&fitness

Aucun commentaire:

Enregistrer un commentaire